Recently, Tianjin Quanhecheng Technology Co., Ltd. (hereinafter referred to as "Quanhecheng") announced the successful completion of a Pre-B round financing of over 100 million yuan.

This round is exclusively invested by Juneng Venture Capital, with Dianshi Capital serving as the exclusive financial advisor. The new round of financing will mainly be used for the development and commercialization of biotechnology chemical raw materials such as nucleic acid drugs, delivery systems, in vitro diagnostics, and downstream applications.

#Small nucleic acid drug raw material track

Since the 2st century, genetic testing has gradually become commercialized. More and more companies are offering genetic testing services, allowing individuals to directly obtain their genetic information. These companies offer diverse testing ranging from genetic disease risk to individual characteristics. At the same time, the concept of personalized medicine has emerged, and genetic testing has been applied in drug selection, disease prevention, and health management.

The market size of China's genetic testing industry in 2020 was RMB 18.201 billion, a year-on-year increase of 23.8%. From 2018 to the first half of 2023, the size of China's genetic testing market gradually increased.

It is expected that in the coming years, with the continuous development of genetic testing technology and the expansion of its application scope, the market size will continue to maintain rapid growth. In the core technologies of genetic testing, including PCR technology, sequencing technology, and nucleic acid mass spectrometry, almost all genetic testing technologies require dNTP as the core raw material.

However, in the early stages of genetic testing development, almost all dNTP products in China relied on imports, which not only had long lead times and high prices, but were also constantly choked by foreign companies! With the outbreak of the COVID-19, the domestic dNTP industry has gradually started.

#Product IntroductionDNTP stands for deoxyribonucleoside triphosphate ate, which includes dATP, dGTP, dTTP, and dCTP. The quality, concentration, and PCR amplification efficiency of dNTP are closely related. After multiple product tests, Quanhecheng has launched a series of high-purity dNTP products with a purity higher than 99.0%, and do not contain nucleases or human and E. coli DNA. This product is designed to meet the needs of various molecular biology experiments.